instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
But as other Democrats already in the race endorse “Medicare-for-all,” Hickenlooper told a crowd at a New Hampshire college that it was more important now to get behind the general idea rather than argue over a specific approach. “I reject the notion that it should become a litmus test of what it takes to be a good Democrat,” said Hickenlooper, who expanded Medicaid while governor and has teamed with former Gov. John Kasich, R-Ohio, on a health care overhaul. The onetime Denver mayor, who’s considered a centrist politician, said after holding a town hall that he will not decide for several more weeks whether to join the crowded 2020 contest. He took questions mostly from students and faculty on topics including student debt, the ballooning national debt and relations with American allies around the world. Hickenlooper said he was concerned that the push for “Medicare-for-all” calls for dismantling the current system when less disruptive measures may achieve universal health care. “There are so many different ways to cut the pie and work on the issue that we too often are trying to say, ‘You’re wrong, I’m right,’ and this is even within the Democrat Party,” he said. “It’s more important to be unified and say we want universal coverage. We are not going to stop until we get universal coverage.” With Sens. Kamala Harris of California and Elizabeth Warren of Massachusetts already running, the challenge for Hickenlooper is showing he is liberal enough to compete. He cited liberal policies he enacted as governor dealing with methane emissions and teenage pregnancies and abortion. “In many ways, I’m a lot more progressive than a lot of these other folks,” he asserted. Hickenlooper also insisted he would have no problem going up against President Donald Trump. “I grew up the skinny kid with thick glasses and a funny last name. I’ve dealt with bullies my whole life,” he said. “The way to deal with a bully is you don’t punch back and take them head on. You take what they say to you and ... you reframe it in a way that reveals the foolishness of what they’re saying and the weakness and insecurity that they’re demonstrating.” After his New Hampshire swing, Hickenlooper is scheduled to give an address at the Global Security Conference in Munich this weekend about trade and the trans-Atlantic partnership. The trip would help burnish the former governor’s foreign policy credentials ahead of any possible presidential campaign.
answer:
Ex-Colorado Gov. Hickenlooper supports universal health care.


question:
"There is no mention of cost. The story could have at least reported what the drug costs in its current use against blood cancer. The story did a good job of explaining both the potential benefits and harms of the drugs. This was a particular strength of this story – and made it stand out in comparison with the LA Times blog story that we also reviewed. Harms were emphasized from the outset – even in the headline – in the AP story but were never mentioned in the LA Times story. And this story reminded readers of the side effects encountered with another MS drug, Tysabri. Outstanding job on this issue by the AP. The story did a very good job of explaining the studies. There is no sign of disease-mongering in this story. Two apparently independent sources were quoted. The story did a good job comparing the new drugs with existing approaches to treat MS. Story explains that the drug is already sold to treat a rare blood cancer and stated that ""it’s too soon to know if the pills will be approved by the government or widely adopted by physicians."" It does not report, however, as the LA TImes blog did, that ""The drug company MD Serono, an affiliate of Merck, has requested approval from the Food and Drug Administration to market the tablet. However it recently received a ""refuse to file"" letter from the FDA, which means the agency is requiring additional information or data. MD Serono said it is pursuing the matter with the FDA and hopes to re-submit its application."" We think that’s a crucial piece of information that affects availability, although, of course, doctors can still prescribe it for off-label use even before the FDA acts on the new request. The novelty of ""tests of the first two oral drugs developed for treating MS"" was clear in the story. It is clear that this story did not rely on a news release."
answer:
MS pills show promise and risk, studies say


question:
U.N. officials and donors met in Geneva to discuss how to tackle the world’s second worst epidemic, which has infected 2,500 people and killed 1,655 in the lush farmlands of eastern Democratic Republic of Congo. A toxic mix of armed militias and a deep-rooted mistrust of health officials by communities have hampered efforts to halt the virus. Goma, a lakeside city more than 350 kilometres (220 miles) south of where the outbreak was first detected, got its first case on Sunday. That raised fears Ebola could accelerate into one of Africa’s most densely populated areas and over the Rwanda border. “The case in Goma could potentially be a gamechanger in this epidemic,” WHO Director-General Tedros Adhanom Ghebreyesus told the meeting. “It is a gateway to the region and the world.”  The patient who brought Ebola to Goma was a priest who became infected during a visit to the town of Butembo, 200 km (124 miles) north of Goma, where he interacted with Ebola patients, Congo’s health ministry said in a statement. He was taken back to a clinic in Butembo on Monday. “Due to the speed with which the patient has been identified and isolated, as well as the identification of all bus passengers from Butembo, the risk of spreading to the rest of the city of Goma remains low,” the ministry said. WHO emergencies chief Mike Ryan said they had identified 60 contacts, including 18 who were on the bus with the priest, and half of them have been vaccinated. Goma had been preparing for the arrival of Ebola for a year, setting up hand-washing stations and making sure moto-taxi drivers do not share helmets. “There is a grave risk of a major increase in numbers, or spread to new locations – as we’ve heard today in Goma,” said Josie Golding, a specialist on epidemics at the Wellcome Trust global health charity. Ebola causes diarrhoea, vomiting and hemorrhagic fever and can be spread through bodily fluids. An epidemic between 2013 and 2016 killed more than 11,300 people in West Africa. While the technology for fighting it, including vaccines and special treatment units, is better than ever, trust between health workers and the community is low — and militia violence is preventing them from accessing remote areas. Unidentified attackers killed two Ebola health workers near Mukulia in North Kivu province over the weekend, the latest in a string of assaults this year that have injured or killed dozens of responders. “Every attack gives Ebola an opportunity to spread. Ebola gets a free ride,” Ghebreyesus said. Apart from insecurity, the biggest challenge is money, officials said. “If we don’t raise more resources ... it is not going to be possible to bring this outbreak under control,” the U.N.’s humanitarian chief Mark Lowcock told Reuters. “The need is for money, not next week, or next month or later in the year. The need is for money now.”
answer:

Ebola spread to east Congo's Goma massively raises risk - U.N.